Zydus Lifesciences submits press release

10 Dec 2022 Evaluate

Zydus Lifesciences has submitted Press release dated December 10, 2022 titled 'Zydus receives two final approvals from the USFDA for Silodosin capsules and Pregabalin capsules'.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

909.30 -17.90 (-1.93%)
08-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1760.00
Dr. Reddys Lab 1207.00
Cipla 1460.60
Zydus Lifesciences 909.30
Lupin 2189.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×